| E88 |
Other and unspecified metabolic disorders |
| E88.0 |
Disorders of plasma-protein metabolism, not elsewhere classified |
| E88.01 |
Alpha-1-antitrypsin deficiency |
| E88.02 |
Plasminogen deficiency |
| E88.09 |
Other disorders of plasma-protein metabolism, not elsewhere classified |
| E88.1 |
Lipodystrophy, not elsewhere classified |
| E88.10 |
Lipodystrophy, unspecified |
| E88.11 |
Partial lipodystrophy |
| E88.12 |
Generalized lipodystrophy |
| E88.13 |
Localized lipodystrophy |
| E88.14 |
HIV-associated lipodystrophy |
| E88.19 |
Other lipodystrophy, not elsewhere classified |
| E88.2 |
Lipomatosis, not elsewhere classified |
| E88.3 |
Tumor lysis syndrome |
| E88.4 |
Mitochondrial metabolism disorders |
| E88.40 |
Mitochondrial metabolism disorder, unspecified |
| E88.41 |
MELAS syndrome |
| E88.42 |
MERRF syndrome |
| E88.43 |
Disorders of mitochondrial tRNA synthetases |
| E88.49 |
Other mitochondrial metabolism disorders |
| E88.8 |
Other specified metabolic disorders |
| E88.81 |
Metabolic syndrome and other insulin resistance |
| E88.810 |
Metabolic syndrome |
| E88.811 |
Insulin resistance syndrome, Type A |
| E88.818 |
Other insulin resistance |
| E88.82 |
Obesity due to disruption of MC4R pathway |
| E88.89 |
Other specified metabolic disorders |
| E88.9 |
Metabolic disorder, unspecified |
| E88.A |
Wasting disease (syndrome) due to underlying condition |
